Log In
Print
BCIQ
Print
Print this Print this
 

ixazomib (MLN9708)

  Manage Alerts
Collapse Summary General Information
Company Takeda Pharmaceutical Co. Ltd.
DescriptionOrally available proteasome inhibitor
Molecular Target Proteasome
Mechanism of ActionProteasome inhibitor
Therapeutic ModalityPeptide

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today